Evidence map›Paper›PMID 36094942›Full record

ArticlePloS one2022

Polymorphisms of adiponectin gene and gene-lipid interaction with hypertension risk in Chinese coal miners: A matched case-control study.

Xiaoqin Hu, Yanfeng Xi, Wenqi Bai, Zhenjun Zhang, Jiahao Qi, Liang Dong, Huiting Liang, Zeyu Sun, Lijian Lei, Guoquan Fan and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Heliyon · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Xiaoqin HuCancer Hospital Affiliated to Shanxi Medical University/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Shanxi Province Cancer Hospital, School of Public Health, Shanxi Medical University, Taiyuan, China.ORCID 0000-0002-0950-9191
Yanfeng XiCancer Hospital Affiliated to Shanxi Medical University/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Shanxi Province Cancer Hospital, Taiyuan, China.
Wenqi BaiCancer Hospital Affiliated to Shanxi Medical University/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Shanxi Province Cancer Hospital, Taiyuan, China.
Zhenjun ZhangCancer Hospital Affiliated to Shanxi Medical University/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Shanxi Province Cancer Hospital, Taiyuan, China.
Jiahao QiSchool of Public Health, Shanxi Medical University, Taiyuan, China.
Liang DongSchool of Public Health, Shanxi Medical University, Taiyuan, China.
Huiting LiangSchool of Public Health, Shanxi Medical University, Taiyuan, China.
Zeyu SunSchool of Public Health, Shanxi Medical University, Taiyuan, China.
Lijian LeiSchool of Public Health, Shanxi Medical University, Taiyuan, China.
Guoquan FanSchool of Public Health, Shanxi Medical University, Taiyuan, China.
Chenming SunSinopharm Tongmei General Hospital, Datong, China.
Cheng HuoSinopharm Tongmei General Hospital, Datong, China.
Jianjun HuangSinopharm Tongmei General Hospital, Datong, China.
Tong WangSchool of Public Health, Shanxi Medical University, Taiyuan, China.ORCID 0000-0002-9403-7167
Shanxi Medical University · CNChina National Pharmaceutical Group Corporation (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveLow serum adiponectin level can predict hypertension development, and adiponectin gene (ADIPOQ) polymorphisms have been reported to be linked with hypertension risk. Whereas, the interaction between ADIPOQ polymorphisms and environmental factors on the susceptibility of hypertension remained unclear. The purpose of this study was to explore the relationship of ADIPOQ polymorphisms with hypertension risk and their interaction with lipid levels in coal miners.

methodsA matched case-control study with 296 case-control pairs was performed in a large coal mining group located in North China. The participants were questioned by trained interviewers, and their ADIPOQ genotype and lipid levels were determined. Logistic regression, stratified analysis, and crossover analysis were applied to evaluate the effects of rs2241766, rs1501299, and rs266729 genotypes and gene-lipid interaction on hypertension risk.

resultsIn this matched case-control study, the genotypes of rs2241766 TG+GG, rs1501299 GT+TT, and rs266729 CG+GG were marginally related to hypertension risk. Individuals with high total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) level were susceptible to hypertension (TC: odds ratio [OR] = 1.807, 95% confidence intervals [95%CI] = 1.266-2.581; LDL-C: OR = 1.981, 95%CI = 1.400-2.803; HDL-C: OR = 1.559, 95%CI = 1.093-2.223). Antagonistic interactions were detected between rs2241766 and TC, rs1501299 and TC, rs2241766 and LDL-C, and rs1501299 and HDL-C (rs2241766 and TC: OR = 0.393, 95%CI = 0.191-0.806; rs1501299 and TC: OR = 0.445, 95%CI = 0.216-0.918; rs2241766 and LDL-C: OR = 0.440, 95%CI = 0.221-0.877; rs1501299 and HDL-C: OR = 0.479, 95%CI = 0.237-0.967). Stratified analysis showed that hypertension risk was high for the subjects with rs2241766 TG+GG or rs1501299 GG under the low lipid level but low for those under the high lipid level. In the case group, the TC and LDL-C levels for rs2241766 TG+GG were lower than those for rs2241766 GG, and the TC and HDL-C levels for rs1501299 GT+TT were higher than those for rs1501299 GG.

conclusionsAlthough the effects of ADIPOQ polymorphisms alone were not remarkable, an antagonistic interaction was observed between ADIPOQ polymorphisms and lipid levels.

Indexed as

AdiponectinHypertensionCase-Control StudiesCholesterol, HDLCholesterol, LDLCoalHumansPolymorphism, Single NucleotideAdiponectinADIPOQ protein, humanCholesterol, HDLCholesterol, LDLCoal

Identifiers

PMID36094942
PMCPMC9467355
OpenAlexW4295467893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.